• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Aclaris lays off 46%, resurrects zunsemetinib for cancer

    FIERCE BIOTECH

    Aclaris Announces Results from 12-Week Phase 2b Trial of Oral Zunsemetinib

    GLOBENEWSWIRE

    Aclaris Therapeutics Completes Enrollment in Phase 2b Study of Oral Zunsemetinib

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.